Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 2,780 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Legal Officer gave up 2,779 shares (to pay taxes)
  4. 4 Shares withheld for taxes President gave up 2,779 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Legal Officer gave up 1,068 shares (to pay taxes)
  6. 4 Shares withheld for taxes President gave up 2,771 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Executive Officer gave up 6,400 shares (to pay taxes)
  8. 4 Shares withheld for taxes President gave up 281 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 780 shares (to pay taxes)
  10. 4 Planned sale Chief Legal Officer sold 529 shares at $44.68 ($23,637)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Planned sale Chief Legal Officer sold 112 shares at $43.30 ($4,849)
  14. 4 Planned sale President sold 314 shares at $43.30 ($13,595)
  15. 4 Planned sale Chief Financial Officer sold 1,420 shares at $42.79 ($60,761)
  16. 4 Planned sale Chief Legal Officer sold 1,418 shares at $42.79 ($60,675)
  17. 4 Planned sale President sold 291 shares at $42.79 ($12,452)
  18. 4 Planned sale President sold 277 shares at $46.10 ($12,771)
  19. 4 Planned sale Chief Financial Officer sold 715 shares at $60.12 ($42,986)
  20. 4 Derivatives Options or other derivatives

Page 6 of 54 · 1,067 filings